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Abstract
The	ionotropic	glutamate	receptors	comprise	members	of	the	NMDA	(N-methyl-D-aspartate),	AMPA
(α-amino-3-hydroxy-5-methyl-4-isoxazoleproprionic	acid)	and	kainate	receptor	classes,	named
originally	according	to	their	preferred,	synthetic,	agonist	[35,	92,	155].	Receptor	heterogeneity
within	each	class	arises	from	the	homo-oligomeric,	or	hetero-oligomeric,	assembly	of	distinct
subunits	into	cation-selective	tetramers.	Each	subunit	of	the	tetrameric	complex	comprises	an
extracellular	amino	terminal	domain	(ATD),	an	extracellular	ligand	binding	domain	(LBD),	3	TM
domains	(M1,	M3	and	M4),	a	channel	lining	re-entrant	'p-loop'	(M2)	located	between	M1	and	M3	and
an	intracellular	carboxy-	terminal	domain	(CTD)	[99,	68,	107,	155,	82].	The	X-ray	structure	of	a
homomeric	ionotropic	glutamate	receptor	(GluA2-	see	below)	has	recently	been	solved	at	3.6Å
resolution	[143]	and	although	providing	the	most	complete	structural	information	current	available
may	not	representative	of	the	subunit	arrangement	of,	for	example,	the	heteromeric	NMDA	receptors
[71].	It	is	beyond	the	scope	of	this	supplement	to	discuss	the	pharmacology	of	individual	ionotropic
glutamate	receptor	isoforms	in	detail;	such	information	can	be	gleaned	from	[35,	66,	31,	77,	42,	114,
24,	65,	155,	112,	113,	162].	Agents	that	discriminate	between	subunit	isoforms	are,	where
appropriate,	noted	in	the	tables	and	additional	compounds	that	distinguish	between	receptor
isoforms	are	indicated	in	the	text	below.
The	classification	of	glutamate	receptor	subunits	has	been	re-addressed	by	NC-IUPHAR
[28].	The	scheme	developed	recommends	a	nomenclature	for	ionotropic	glutamate	receptor	subunits
that	is	adopted	here.
NMDA	receptors
NMDA	receptors	assemble	as	obligate	heteromers	that	may	be	drawn	from	GluN1,	GluN2A,	GluN2B,
GluN2C,	GluN2D,	GluN3A	and	GluN3B	subunits.	Alternative	splicing	can	generate	eight	isoforms	of
GluN1	with	differing	pharmacological	properties.	Various	splice	variants	of	GluN2B,	2C,	2D	and
GluN3A	have	also	been	reported.	Activation	of	NMDA	receptors	containing	GluN1	and	GluN2
subunits	requires	the	binding	of	two	agonists,	glutamate	to	the	S1	and	S2	regions	of	the	GluN2
subunit	and	glycine	to	S1	and	S2	regions	of	the	GluN1	subunit	[41,	25].	The	minimal	requirement	for
efficient	functional	expression	of	NMDA	receptors	in	vitro	is	a	di-heteromeric	assembly	of	GluN1	and
at	least	one	GluN2	subunit	variant,	as	a	dimer	of	heterodimers	arrangement	in	the	extracellular
domain	[48,	99,	71].	However,	more	complex	tri-heteromeric	assemblies,	incorporating	multiple
subtypes	of	GluN2	subunit,	or	GluN3	subunits,	can	be	generated	in	vitro	and	occur	in	vivo.	The
NMDA	receptor	channel	commonly	has	a	high	relative	permeability	to	Ca2+	and	is	blocked,	in	a
voltage-dependent	manner,	by	Mg2+	such	that	at	resting	potentials	the	response	is	substantially
inhibited.
AMPA	and	Kainate	receptors
AMPA	receptors	assemble	as	homomers,	or	heteromers,	that	may	be	drawn	from	GluA1,	GluA2,
GluA3	and	GluA4	subunits.	Transmembrane	AMPA	receptor	regulatory	proteins	(TARPs)	of	class	I
(i.e.	γ2,	γ3,	γ4	and	γ8)	act,	with	variable	stoichiometry,	as	auxiliary	subunits	to	AMPA	receptors	and
influence	their	trafficking,	single	channel	conductance	gating	and	pharmacology	(reviewed	in	[43,
103,	153,	64]).	Functional	kainate	receptors	can	be	expressed	as	homomers	of	GluK1,	GluK2	or
GluK3	subunits.	GluK1-3	subunits	are	also	capable	of	assembling	into	heterotetramers	(e.g.
GluK1/K2;	[87,	119,	118]).	Two	additional	kainate	receptor	subunits,	GluK4	and	GluK5,	when
expressed	individually,	form	high	affinity	binding	sites	for	kainate,	but	lack	function,	but	can	form
heteromers	when	expressed	with	GluK1-3	subunits	(e.g.	GluK2/K5;	reviewed	in	[119,	65,	118]).
Kainate	receptors	may	also	exhibit	'metabotropic'	functions	[87,	131].	As	found	for	AMPA	receptors,
kainate	receptors	are	modulated	by	auxiliary	subunits	(Neto	proteins,	[118,	88]).	An	important
function	difference	between	AMPA	and	kainate	receptors	is	that	the	latter	require	extracellular	Na+
and	Cl-	for	their	activation	[11,	120].	RNA	encoding	the	GluA2	subunit	undergoes	extensive	RNA
editing	in	which	the	codon	encoding	a	p-loop	glutamine	residue	(Q)	is	converted	to	one	encoding
arginine	(R).	This	Q/R	site	strongly	influences	the	biophysical	properties	of	the	receptor.
Recombinant	AMPA	receptors	lacking	RNA	edited	GluA2	subunits	are:	(1)	permeable	to	Ca2+;	(2)
blocked	by	intracellular	polyamines	at	depolarized	potentials	causing	inward	rectification	(the	latter
being	reduced	by	TARPs);	(3)	blocked	by	extracellular	argiotoxin	and	joro	spider	toxins	and	(4)
demonstrate	higher	channel	conductances	than	receptors	containing	the	edited	form	of	GluA2	[139,
63].	GluK1	and	GluK2,	but	not	other	kainate	receptor	subunits,	are	similarly	edited	and	broadly
similar	functional	characteristics	apply	to	kainate	receptors	lacking	either	an	RNA	edited	GluK1,	or
GluK2,	subunit	[87,	118].	Native	AMPA	and	kainate	receptors	displaying	differential	channel
conductances,	Ca2+	permeabilites	and	sensitivity	to	block	by	intracellular	polyamines	have	been
identified	[30,	63,	91].	GluA1-4	can	exist	as	two	variants	generated	by	alternative	splicing	(termed
‘flip’	and	‘flop’)	that	differ	in	their	desensitization	kinetics	and	their	desensitization	in	the	presence	of
cyclothiazide	which	stabilises	the	nondesensitized	state.	TARPs	also	stabilise	the	non-desensitized
conformation	of	AMPA	receptors	and	facilitate	the	action	of	cyclothiazide	[103].	Splice	variants	of
GluK1-3	also	exist	which	affects	their	trafficking	[87,	118].
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